Postmarket surveillance of high-risk medical devices needs transparent, comprehensive and independent registries

Postmarket surveillance of high-risk medical devices needs transparent, comprehensive and independent registries

Bibliographic Details
Main Author:	Alan G Fraser
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	BMJ Surgery, Interventions, & Health Technologies
Online Access:	https://sit.bmj.com/content/2/1/e000065.full

Similar Items

Current development in medical devices postmarket surveillance in Taiwan
by: Cheng-Wen Lan, et al.
Published: (2015-03-01)

Security and privacy qualities of medical devices: an analysis of FDA postmarket surveillance.
by: Daniel B Kramer, et al.
Published: (2012-01-01)

Postmarket sequential database surveillance of medical products
by: Maro, Judith C
Published: (2013)

Sleep-walking with zolpidem: Need for continued postmarketing surveillance
by: Ajitha Sharma, et al.
Published: (2015-01-01)

Postmarket surveillance of medical devices: a comparison of strategies in the US, EU, Japan, and China.
by: Daniel B Kramer, et al.
Published: (2013-01-01)

Postmarketing Safety Study Tool: A Web Based, Dynamic, and Interoperable System for Postmarketing Drug Surveillance Studies
by: A. Anil Sinaci, et al.
Published: (2015-01-01)

Postmarketing surveillance of sumatriptan : patient population, efficacy, and adverse effects
by: Wang, Yu-Chin Lily
Published: (1994)

Rotavirus Vaccine Withdrawal in the United States: The Role of Postmarketing Surveillance
by: Gilles Delage
Published: (2000-01-01)

Evaluation of the quality and value of data sources for postmarket surveillance of the safety of cough and cold medications in children
by: Jody L. Green, et al.
Published: (2018-12-01)

Update regarding opportunities for orthopaedic surgeons to contribute to postmarket surveillance of potential safety issues for orthopaedic medical devices marketed in the United States
by: Vincent J. Devlin, MD
Published: (2017-12-01)

Rapid Diagnostic Tests for Neglected Infectious Diseases: Case Study Highlights Need for Customer Awareness and Postmarket Surveillance.
by: Barbara Barbé, et al.
Published: (2016-11-01)

Postmarket surveillance of 3D-printed implants for sacroiliac joint fusion
by: Cher D, et al.
Published: (2018-09-01)

A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy
by: Rod P. Bonello, et al.
Published: (2014-01-01)

Postmarketing Safety Surveillance and Reevaluation of Danhong Injection: Clinical Study of 30888 Cases
by: Xue-Lin Li, et al.
Published: (2015-01-01)

Safety and Antihypertensive Effect of Selara® (Eplerenone): Results from a Postmarketing Surveillance in Japan
by: Shoko Takahashi, et al.
Published: (2016-01-01)

Self-controlled methods for postmarketing drug safety surveillance in large-scale longitudinal data
by: Simpson, Shawn E.
Published: (2011)

Pharmacodynamic analysis of hypertension caused by lenvatinib using real‐world postmarketing surveillance data
by: Yuki Otani, et al.
Published: (2021-03-01)

Safety and tolerability of fluvastatin XL in the treatment of hyper-cholesterolemia : a postmarketing surveillance conducted in Indonesia
by: Arini Setiawati, et al.
Published: (2008-05-01)

Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan
by: Furuya, T., et al.
Published: (2022)

AMCP Partnership Forum: Biosimilars—policy, practice, and postmarketing surveillance to support treatment and coverage decisions
by: Dharbhamalla, V.
Published: (2021)

Monitoring temporal changes in the specificity of an oral HIV test: a novel application for use in postmarketing surveillance.
by: Joseph R Egger, et al.
Published: (2010-08-01)

Postmarket surveillance: a review on key aspects and measures on the effective functioning in the context of the United Kingdom and Canada
by: Nikhil Raj, et al.
Published: (2019-07-01)

In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorthiazide, among Palestinian hypertensive patients
by: Zaid AN, et al.
Published: (2016-09-01)

Development of methodologies for improvement in signal detection using prescription-event monitoring as a postmarketing surveillance platform
by: Ferreira, Germano L. C.
Published: (2008)

Correction: Typical use effectiveness of Natural Cycles: postmarket surveillance study investigating the impact of previous contraceptive choice on the risk of unintended pregnancy
by: Julie HT Dang, et al.
Published: (2019-06-01)

Postmarketing safety surveillance of dexamethasone intravitreal implant in the treatment of visual impairment due to diabetic macular edema in India
by: Unnikrishnan Nair, et al.
Published: (2020-10-01)

Comparison of Data Mining Methods for the Signal Detection of Adverse Drug Events with a Hierarchical Structure in Postmarketing Surveillance
by: Goeun Park, et al.
Published: (2020-08-01)

Safety and effectiveness of rapid-acting intramuscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study
by: Katagiri H, et al.
Published: (2018-01-01)

Sucrose-Formulated Recombinant Factor VIII Dosing Flexibility in Prophylaxis Regimens: Experience from Postmarketing Surveillance Studies
by: Thomas J. Humphries, et al.
Published: (2015-01-01)

Clinical efficacy and safety of alemtuzumab in postmarketing practice
by: N. V. Khachanova
Published: (2019-06-01)

The Adverse Drug Reactions Registered During the Postmarketing Period
by: E. V. Shubnikova, et al.
Published: (2019-03-01)

Orphan Therapies: Making Best Use of Postmarket Data
by: Li, Lingling, et al.
Published: (2016)

Safety and effectiveness of apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A regulatory postmarketing surveillance, the STANDARD study
by: Hiroshi Inoue, et al.
Published: (2019-06-01)

Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behçet’s disease: a large-scale, long-term postmarketing surveillance in Japan
by: Shigeaki Ohno, et al.
Published: (2019-01-01)

Real-World Outcomes of Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration: A Large-Scale Postmarketing Surveillance in Korea
by: Ryu G, et al.
Published: (2021-08-01)

An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland, who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray
by: Etges T, et al.
Published: (2016-11-01)

Development of a public health information infrastructure for postmarket evidence
by: Maro, Judith C
Published: (2010)

Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF‐Japan): One‐year safety and effectiveness analyses
by: Takeshi Yamashita, et al.
Published: (2020-06-01)

Postmarketing surveillance on clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF‐Japan): Three‐month interim analysis results
by: Takeshi Yamashita, et al.
Published: (2019-02-01)

Safety and effectiveness of controlled-release paroxetine in routine clinical practice: results of a postmarketing surveillance study of patients with depression
by: Kato M, et al.
Published: (2015-02-01)

Cannot write session to /tmp/vufind_sessions/sess_kd1ht7gpv7nc0k65v8812r7qhf